Fig. 1
Autologous mesenchymal stem cell concentrate: (a) autologous bone marrow autograft, (b) centrifugation process with a single spin, and (c) layer separation by a density filter and identification of mononuclear cells layer. (d) Autologous mononuclear cells concentrate – final view
Summary
Hip chondral lesions are a frequent finding in hip arthroscopy for FAI. Treatment is often difficult and insufficient. Novel strategies based on cell regenerative therapy represent an interesting treatment alternative. We reviewed the general concepts of hip chondral lesions treatment and the stem cell background.
In the next part of the chapter, we will discuss different treatment options for hip chondral lesions with the use of mesenchymal stem cells.
References
1.
2.
Bedi A, Lynch EB, Sibilsky Enselman ER, et al. Elevation in circulating biomarkers of cartilage damage and inflammation in athletes with femoroacetabular impingement. Am J Sports Med. 2013;41:2585–90.PubMedCentralPubMedCrossRef
3.
4.
5.
6.
Kaplan LD, Chu CR, Bradley JP, Fu FH, Studer RK. Recovery of chondrocyte metabolic activity after thermal exposure. Am J Sports Med. 2003;31(3):392–8.PubMed
7.
Lotto ML, Wright EJ, Appleby D, Zelicof SB, Lemos MJ, Lubowitz JH. Ex vivo comparison of mechanical versus thermal chondroplasty: assessment of tissue effect at the surgical endpoint. Arthroscopy. 2008;24(4):410–5.PubMedCrossRef